本文選題：胃腫瘤 + Lauren分型��； 參考：《中國全科醫(yī)學》2017年13期

【摘要】：目的探討腸型胃癌和彌漫型胃癌的臨床特點及預后。方法選取2007-01-01至2015-12-30在長治醫(yī)學院附屬和平醫(yī)院外科病房手術治療的胃癌患者392例,其中腸型231例(58.9%),彌漫型161例(41.1%)。建立胃癌流行病學調查問卷,并由經過培訓的專業(yè)人員按統(tǒng)一標準采集胃癌患者信息,包括基本情況(性別、年齡、身高、體質量、文化程度、婚姻狀況、血型、幽門螺桿菌感染、腫瘤家族史)、生活方式及習慣(吸煙、飲酒、進食速度、進食燙食、進食酸菜/咸菜/泡菜、進食油炸食品)及病理診斷與臨床分期等;并由本院中心實驗室具有碩士及以上學歷人員對患者進行電話隨訪,詢問生存情況,隨訪截至2015-12-30。結果腸型與彌漫型胃癌患者性別、體質指數(BMI)、文化程度、婚姻狀況、血型、幽門螺桿菌感染、腫瘤家族史比較,差異無統(tǒng)計學意義(P0.05);腸型與彌漫型胃癌患者年齡比較,差異有統(tǒng)計學意義(P0.05)。腸型與彌漫型胃癌患者吸煙、飲酒比較,差異有統(tǒng)計學意義(P0.05);腸型與彌漫型胃癌患者進食速度、進食燙食、進食酸菜/咸菜/泡菜、進食油炸食品比較,差異無統(tǒng)計學意義(P0.05)。腸型與彌漫型胃癌患者T期、M期比較,差異無統(tǒng)計學意義(P0.05);腸型與彌漫型胃癌患者N期比較,差異有統(tǒng)計學意義(P0.05)。340例胃癌患者完成隨訪,隨訪率為86.7%;截至隨訪日期,腸型胃癌患者生存率為66.5%(129/194),中位生存時間為24個月;彌漫型胃癌患者生存率為52.7%(77/146),中位生存時間為18個月。腸型與彌漫型胃癌患者生存曲線比較,差異有統(tǒng)計學意義(P0.05)。結論不同Lauren分型胃癌臨床特點和預后不同。Lauren分型在胃癌治療及預防中起一定的決策作用。
[Abstract]:Objective to investigate the clinical features and prognosis of intestinal and diffuse gastric cancer. Methods 392 patients with gastric cancer were selected from January 1, 2007 to May 12, 2015-30 in the surgical ward of the affiliated Peace Hospital of Changzhi Medical College. 231 cases of intestinal type and 161 cases of diffuse type were selected. A questionnaire on gastric cancer epidemiology was established and trained professionals were trained to collect information on gastric cancer patients according to uniform criteria, including basic information (sex, age, height, body mass, education, marital status, blood type). Helicobacter pylori infection, family history of cancer, lifestyle and habits (smoking, drinking, eating speed, eating hot food, eating pickles / pickles, eating fried food), pathological diagnosis and clinical stages. And from the central laboratory of our hospital with master's degree and above to carry on the telephone follow-up to the patient, inquire the survival condition, follow up to 2015-12-30. Results there was no significant difference in sex, BMI, education, marital status, blood group, Helicobacter pylori infection, family history of tumor between intestinal type and diffuse type of gastric cancer (P 0.05). The difference was statistically significant (P 0.05). There was significant difference in smoking and drinking between intestinal type and diffuse type of gastric cancer (P 0.05), but there was no significant difference between intestinal type and diffuse type of gastric cancer in terms of eating speed, hot food, pickle / pickle and fried food (P 0.05). There was no significant difference in T phase M stage between intestinal type and diffuse type of gastric cancer, but there was no significant difference between intestinal type and diffuse type of gastric cancer in N stage, and there was significant difference in P 0.05% and 340 cases of gastric cancer with a follow-up rate of 86.7%. The survival rate of patients with intestinal type gastric cancer was 12.9 / 194, the median survival time was 24 months, and the survival rate of diffuse gastric cancer patients was 52.777 / 146, with a median survival time of 18 months. There was significant difference in survival curve between intestinal type and diffuse type of gastric cancer (P 0.05). Conclusion the clinical characteristics and prognosis of gastric cancer with different Lauren types are different. Lauren's classification plays a decisive role in the treatment and prevention of gastric cancer.
【作者單位】： 長治醫(yī)學院預防醫(yī)學系流行病與衛(wèi)生統(tǒng)計學教研室;長治醫(yī)學院附屬和平醫(yī)院中心實驗室;
【基金】：山西省基礎研究計劃項目(2015021185) 國家自然科學基金資助項目(81302518) 山西省長治醫(yī)學院創(chuàng)新團隊(CX201403)
【分類號】：R735.2

【相似文獻】

相關期刊論文 前10條

1 彭開勤;;遺傳性彌漫型胃癌[J];臨床外科雜志;2007年07期

2 彭敦發(fā);;彌漫型胃癌的分子發(fā)生學研究進展[J];皖南醫(yī)學院學報;2013年05期

3 邱瑞成,吳小平;彌漫型胃癌48例臨床病理分析[J];中國誤診學雜志;2003年02期

4 邱瑞成,吳小平,李萍,唐思洪;彌漫型胃癌48例病理組織學分析[J];診斷病理學雜志;2004年04期

5 徐有坤;吳正榮;李強;;彌漫型胃癌168例病理組織學分析[J];武警醫(yī)學;2006年03期

6 周志華;張建東;趙海濱;;胃干細胞與彌漫型胃癌的發(fā)生[J];國際消化病雜志;2010年02期

7 劉群;侯云修;;幽門螺桿菌感染、炎癥與彌漫型胃癌[J];中華臨床醫(yī)師雜志(電子版);2013年13期

8 施敏明,黃彩兒;HP陽性淺表性胃炎與彌漫型胃癌的關系探討[J];臨床消化病雜志;1996年01期

9 汪海丹,任軍,賈軍,斯曉明,黃若宇,張燕軍,張聯,張陽;散發(fā)性腸型和遺傳性彌漫型胃癌中上皮鈣黏附素的表達差異及意義[J];現代腫瘤醫(yī)學;2005年03期

10 張曉青,楊燕青,劉炳亞,金曉龍,李煒,張慶華,林言箴,朱正綱;彌漫型胃癌基因表達譜聚類分析[J];診斷學理論與實踐;2005年03期

相關會議論文 前4條

1 應杰兒;徐艷瑁;曹文明;應莉莎;徐琦;程向東;;中國早發(fā)彌漫型胃癌CDH1基因突變的檢測[A];第9屆全國胃癌學術會議暨第二屆陽光長城腫瘤學術會議論文匯編[C];2014年

2 應杰兒;徐艷s，

本文編號：1913303